NCI-MATCH precision medicine cancer trial (IMAGE)
Caption
NCI-MATCH is a precision medicine cancer trial that seeks to determine whether matching certain drugs or drug combinations in adults whose tumors have specific gene abnormalities will effectively treat their cancer, regardless of their cancer type. Such discoveries could be eligible to move on to larger, more definitive trials. The trial is led by the ECOG-ACRIN Cancer Research Group.
Credit
ECOG-ACRIN Cancer Research Group
Usage Restrictions
None
License
Licensed content